Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RAPT Therapeutics (RAPT) Revenue: 2020-2022

Historic Revenue for Therapeutics (RAPT) over the last 3 years, with Dec 2022 value amounting to $1.5 million.

  • Therapeutics' Revenue rose 1.96% to $886,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $3.2 million, marking a year-over-year decrease of 33.98%. This contributed to the annual value of $1.5 million for FY2022, which is 59.95% down from last year.
  • Therapeutics' Revenue amounted to $1.5 million in FY2022, which was down 59.95% from $3.8 million recorded in FY2021.
  • Therapeutics' Revenue's 5-year high stood at $5.0 million during FY2020, with a 5-year trough of $1.5 million in FY2022.
  • Its 3-year average for Revenue is $3.5 million, with a median of $3.8 million in 2021.
  • Data for Therapeutics' Revenue shows a maximum YoY tumbled of 59.95% (in 2022) over the last 5 years.
  • Therapeutics' Revenue (Yearly) stood at $5.0 million in 2020, then fell by 24.38% to $3.8 million in 2021, then crashed by 59.95% to $1.5 million in 2022.